Helmholtz Gemeinschaft


Browse by Journal Title

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type
Jump to: 2019 | 2017 | 2016 | 2013 | 2011 | 2008


Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial.
Levin, J. and Maaß, S. and Schuberth, M. and Giese, A. and Oertel, W.H. and Poewe, W. and Trenkwalder, C. and Wenning, G.K. and Mansmann, U. and Südmeyer, M. and Eggert, K. and Mollenhauer, B. and Lipp, A. and Löhle, M. and Classen, J. and Münchau, A. and Kassubek, J. and Gandor, F. and Berg, D. and Egert-Schwender, S. and Eberhardt, C. and Paul, F. and Bötzel, K. and Ertl-Wagner, B. and Huppertz, H.J. and Ricard, I. and Höglinger, G.U.
Lancet Neurology 18 (8): 724-735. August 2019

Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders.
Ciccarelli, O. and Cohen, J.A. and Reingold, S.C. and Weinshenker, B.G.
Lancet Neurology 18 (2): 185-197. February 2019


Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis.
Petzold, A. and Balcer, L.J. and Calabresi, P.A. and Costello, F. and Frohman, T.C. and Frohman, E.M. and Martinez-Lapiscina, E.H. and Green, A.J. and Kardon, R. and Outteryck, O. and Paul, F. and Schippling, S. and Vermersch, P. and Villoslada, P. and Balk, L.J.
Lancet Neurology 16 (10): 797-812. October 2017


What is the future of proof of concept studies in multiple sclerosis?
Paul, F.
Lancet Neurology 15 (11): 1107-1109. October 2016

Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.
Martinez-Lapiscina, E.H. and Arnow, S. and Wilson, J.A. and Saidha, S. and Preiningerova, J.L. and Oberwahrenbrock, T. and Brandt, A.U. and Pablo, L.E. and Guerrieri, S. and Gonzalez, I. and Outteryck, O. and Mueller, A.K. and Albrecht, P. and Chan, W. and Lukas, S. and Balk, L.J. and Fraser, C. and Frederiksen, J.L. and Resto, J. and Frohman, T. and Cordano, C. and Zubizarreta, I. and Andorra, M. and Sanchez-Dalmau, B. and Saiz, A. and Bermel, R. and Klistorner, A. and Petzold, A. and Schippling, S. and Costello, F. and Aktas, O. and Vermersch, P. and Oreja-Guevara, C. and Comi, G. and Leocani, L. and Garcia-Martin, E. and Paul, F. and Havrdova, E. and Frohman, E. and Balcer, L.J. and Green, A.J. and Calabresi, P.A. and Villoslada, P.
Lancet Neurology 15 (6): 574-584. May 2016


From mice to man: chloride transport in leukoencephalopathy.
Jentsch, T.J.
Lancet Neurology 12 (7): 626-628. July 2013


Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study.
Barthel, H. and Gertz, H.J. and Dresel, S. and Peters, O. and Bartenstein, P. and Buerger, K. and Hiemeyer, F. and Wittemer-Rump, S.M. and Seibyl, J. and Reininger, C. and Sabri, O.
Lancet Neurology 10 (5): 424-435. May 2011


Treatment-resistant chronic headaches and focal pachymeningitis in a 46-year-old man: a rare presentation of Wegener's granulomatosis.
Doerr, J. and Elitok, S. and Dieste, F.J. and Vogel, H.P. and Schneider, W. and Wuerfel, J. and Zipp, F. and Paul, F.
Lancet Neurology 7 (4): 368-372. April 2008

This list was generated on Wed Jan 29 02:27:57 2020 CET.
Open Access
MDC Library